T cell receptor beta joining 1-2 (TRBJ1-2)

T cell receptor beta joining 1-2 (TRBJ1-2) is a gene segment encoding a portion of the J (joining) region in the variable domain of the T cell receptor (TCR) beta chain[1][3][5]. The TCR is a membrane-bound heterodimeric receptor mostly comprised of an alpha (α) and beta (β) chain on T cells, playing a crucial role in adaptive immunity by mediating antigen recognition[6][2]. Diversity in the TCR repertoire is generated by somatic rearrangement of variable (V), diversity (D), and joining (J) gene segments in the TCR beta locus. TRBJ1-2 is one of several J gene segments utilized in this recombination, contributing sequence diversity to the complementarity-determining region 3 (CDR3) of the beta chain, which is essential for specific peptide-MHC binding by T cells[1][3][5]. TRBJ1-2 itself is not considered a direct therapeutic target, druggable receptor, or enzyme; rather, it is a component of the genetic architecture that underlies the diversity and specificity of T cell antigen recognition[5][6]. There are no drugs known to interact directly with TRBJ1-2, nor is it a biomarker or a safety concern on its own. However, TCR repertoire analysis (including TRBJ gene usage) can be relevant in immunological diagnostics and research.

Other names

TRBJ1-2TRBJ12TCRBJ1S2